USA TODAY – Researchers from the University of Utah analyzed vaccination data from the Centers for Disease Control and Prevention starting July 25, a month before full FDA approval, to Sept. 9, the day before President Joe Biden made his vaccine mandate announcement. Using the vaccination rate leading up to full approval, they estimated how many doses would have been administered compared to the actual recorded number. Study authors found FDA approval was associated with an overall 36% increase in vaccinations, but most were second doses. First doses, they found, were 16% lower than predicted. Health experts are not surprised by the study’s findings.
Continue Reading at USA TODAY
